Beyond diagnosing acute kidney injury: defining what we need from kidney biomarkers
Author:
Open Access
- 8 October 2026
- journal article
- editorial
- Published by Springer Nature in Pediatric Research
- p. 1-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- TIMP-2 and IGFBP7 for the differentiation of functional and intrinsic pediatric acute kidney injuryPediatric Research, 2026
- The promise of biomarkers: precision medicine will pave a roadmap for pediatric acute kidney injury management in critically ill childrenIntensive Care Medicine – Paediatric and Neonatal, 2025
- The use of urinary biomarkers as prognostic tools: predicting kidney outcomes in pediatric acute kidney injuryPediatric Nephrology, 2025
- A proposed framework for advancing acute kidney injury risk stratification and diagnosis in children: a report from the 26th Acute Disease Quality Initiative (ADQI) conferencePediatric Nephrology, 2023
- A risk-stratified assessment of biomarker-based acute kidney injury phenotypes in childrenPediatric Research, 2022
- Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus ConferenceJAMA Network Open, 2020
- Epidemiology of Acute Kidney Injury in Critically Ill Children and Young AdultsNew England Journal of Medicine, 2017
- Urinary biomarkers for the differentiation of prerenal and intrinsic pediatric acute kidney injuryPediatric Nephrology, 2016
- Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney InjuryPLOS ONE, 2015
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryCritical Care, 2013